# Final Integrated Run Review

**Run:** `retinopathy-final-itu-criteria-20261103-4`  
**Model:** local `qwen3:8b`  
**Review date:** 3 November 2026

## Run integrity and outcome

- 32 agent decisions were recorded; all selected actions were within the actor allow-lists.
- `make verify-log RUN=retinopathy-final-itu-criteria-20261103-4` verified the hash chain.
- Two governance assessments were emitted in `gaps.jsonl`. Both have status `INSUFFICIENT_EVIDENCE`; neither is a confirmed legal or policy gap.
- Three EDE manufacturer-evidence requests cite Federal Decree-Law No. 38/2024 Articles 68(7) and 70(2). Their rationales keep the statutory predicates unresolved, frame the requests as simulated fact-finding rather than a duty, and cap confidence at 0.5. The references are to the English translation; the Arabic original controls.

## Citation screen

`make audit-evidence` reported 14 decisions without citations and two DHA citations needing review. The tool uses lexical and metadata screening; it cannot establish exact legal support, mandate or applicability.

The two flagged citations are `log-2-dha` and `log-6-dha`. Each cites `AE-DHA-REFERRAL-2022:p1:c2` and is marked `UNSUPPORTED` by the screen. The passage describes the policy's Dubai health-facility scope and continuity-of-care/referral purpose. It does not establish that the scenario clinics are DHA-licensed or that an AI-specific incident follow-up duty applies. The logged rationales state those limits and cap confidence at 0.5. A human should not convert these references into a legal duty.

The 14 decisions with no citation are:

`log-1-screening_ai`, `log-1-retina_swiss_ag`, `log-2-screening_ai`, `log-3-retina_swiss_ag`, `log-3-uae_cyber`, `log-4-retina_swiss_ag`, `log-5-retina_swiss_ag`, `log-7-screening_ai`, `log-7-dubai_clinic_operator`, `log-7-retina_swiss_ag`, `log-7-uae_cyber`, `log-7-ncsc`, `log-7-policy_adviser`, and `log-8-dubai_clinic_operator`.

These entries include operational choices made from facts visible in the synthetic scenario as well as source-based assertions. Lack of a citation does not by itself mean the action is wrong, but source-based policy or legal claims should remain unsubstantiated until individually reviewed. The run is therefore useful as an auditable drill, not a validated measure of citation accuracy.

The Swiss vendor's rollback entry (`log-7-retina_swiss_ag`) has no citation. Its rationale treats rollback as a proposal pending human approval and says availability and safety are unverified; it does not cite the unrelated WHO passage used in the previous run.

## Governance assessments

1. `CLINICAL-CONFLICT-001` records a synthetic safety-versus-access conflict: false negatives are confirmed in the scenario, while manual screening capacity, patient follow-up and rollback safety remain unknown. It recommends human assessment and is `INSUFFICIENT_EVIDENCE`.
2. `GAP-HEALTH-001` records unresolved evidence-sharing and incident-coordination questions. Controller roles, image identifiability/provenance, processing and transfer basis, liaison-route authority, and passage-level support remain unresolved. It is `INSUFFICIENT_EVIDENCE`; its global comparison is explicitly unvalidated.

## Interpretation limits

The run uses fictional product and incident facts. The product dossier's classification letter is fictional and establishes classification only for the drill. Real product classification, authorization, clinic licensing, patient outcomes and incident predicates remain unknown. The run does not prove compliance, non-compliance, a statutory reporting duty or a regulatory policy gap. Arabic source interpretation has not had independent human Arabic review.
